Sharing large-scale patient data to understand COVID-19 severity

HCS and ASIP member Dr. Alejandro Adam recently co-authored two preprints with collaborators at Albany Medical College, the University of Wisconsin, Madison and the Morgridge Institute for Research. This research, led by Drs. Ariel Jaitovich (Albany Med) and Joshua Coon (UW-Madison), shows how multiplexed measurements, large-scale multi-omics analysis and artificial intelligence can shed light into [...]

Long-time ASIP Member L. Maximilian Buja, MD in the news for autopsy research unlocking new COVID Treatments

L. Maximilian Buja, MD Dr. Buja is Professor of Pathology and Laboratory Medicine and Distinguished Teaching Professor at the McGovern Medical School of the University of Texas Health Science Center at Houston. His scholarly focus is on pathogenesis of cardiovascular diseases. He is an advocate of the importance of the autopsy in medicine and has [...]

A Hypothesized Role for Dysregulated Bradykinin Signaling in COVID-19 Respiratory Complications

ASIP member Dr. Joseph Roche (Wayne State University) recently published a paper in FASEB J. along with co-author Dr. Renuka Roche (Eastern Michigan University). Their paper hypothesizes a bradykinin [BK] model for COVID-19 complications and they suggest use of the FDA-approved BK blocker in the treatment of patients with COVID-19 respiratory disease. The abstract from [...]

COVID Autopsy Series by ASIP member Richard Vander Heide, MD from LSU Health New Orleans reveals new cardiopulmonary findings

Richard Vander Heide, MD, PhD LSU Health New Orleans pathologists performed the first series of autopsies on African Americans who died from COVID-19 in New Orleans, and their findings provide new and critical information to guide patient management. The findings are published in The Lancet Respiratory Medicine, available here. “We found that the small vessels [...]